CytoSorbents Corporation (CTSO)

[orangecat]

"De-risked" is the newest term that has been added to the investor presentations, starting with the Q4 2016 presentation.

Below, I included an excerpt from short article on the subject from the site mindsheet.

I find it encouraging that the person with the most inside information on the commercialization of Cytosorb now considers the company and product "de-risked". I think the many new and expanded partnerships, accelerating sales by the Cytosorbents Sales Team and a German hospital with annual purchases over a million dollars have demonstrated that there is now little market risk with Cytosorb. The physicians who have tried the product are getting good results and that is leading to increased adoption and sales numbers.

From mindsheet:
There are three major areas of risk in the product development process when it comes to developing new hi-tech products:

Technology risk
Management risk
Market risk

We tend to dwell on the first two, because that is what you’re aware of on a day to day basis.

Will the technology work? Do you have good development and communication processes? Do you have the right people? is the project on track? and so on… All best practices in the Stage Gate Process.

But by far the biggest area of risk is the third one – market risk. Think about it, you only really know if you’ve got a flop on your hand when you launch the new product into the market. By that stage, you’ve already spent all of the development budget.